Cancer Biomarker Detection With Luminex Assays
Luminex and Bio-Techne are working together to support the development of early diagnostic solutions that detect cancer earlier through the use of proteomics.
Charles Rosser, a research scientist and professor of biomedical sciences, has developed a multiplex test for early-stage bladder cancer using Luminex® xMAP® Technology. Bladder cancer affects over 570,000 people globally each year, and the Oncuria® test aims to detect bladder cancer, monitors for recurrence, and predicts which patients will benefit from the immunotherapy treatment. Current diagnostic assays lack sensitivity and do not provide a comprehensive view of the cancer’s molecular profile, but the Oncuria® test covers 10 glycoproteins to detect the biological signature of bladder cancer with sensitivity of 90% to 93% and specificity of 86% to 95%. The test received Breakthrough Device Designation status from the FDA and is currently available as a laboratory-developed test (LDT). In a recent clinical validation study involving about 350 patients, the test offered 93% sensitivity. Learn more about this major shift in the care of patients with bladder cancer.
R&D Systems: Luminex® Assays
Bead-based multiplex assay using Luminex technology. In a 96 well
Multiplexed Cytokines (Luminex) – DartLab
Application of Luminex Technology in Clinical and Scientific Research - Creative Proteomics
Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arrays - Analyst (RSC Publishing) DOI:10.1039/C6AN01076H
The recent advancements in the early detection of cancer biomarkers by DNAzyme-assisted aptasensors, Journal of Nanobiotechnology
Luminex immunosandwich assay and IP-MS approach.(a) The left panel
Auxiliary diagnosis of Lung Cancer on the basis of a Serum Protein Biomarker Panel
Luminex Assay Principle: R&D Systems
MILLIPLEX MAP Human Circulating Cancer Biomarker Magnetic Bead Panel 2 - Cancer Multiplex Assay
Cancer Biomarker Detection With Luminex Assays
Novel modification of Luminex assay for characterization of extracellular vesicle populations in biofluids
Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy
Bio-Plex Multiplex Immunoassay System
Cancer Biomarker Detection With Luminex Assays
